tiprankstipranks
HUTCHMED Announces Approval of Key Resolution at Extraordinary General Meeting
PremiumCompany AnnouncementsHUTCHMED Announces Approval of Key Resolution at Extraordinary General Meeting
2M ago
Hutchmed says NDA for Tazverik granted conditional approval in China
Premium
The Fly
Hutchmed says NDA for Tazverik granted conditional approval in China
2M ago
HUTCHMED Secures NMPA Approval for TAZVERIK® in China
Premium
Company Announcements
HUTCHMED Secures NMPA Approval for TAZVERIK® in China
2M ago
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
PremiumThe FlyHutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
2M ago
Hutchmed reports FY24 EPS 22c vs. 59c last year
Premium
The Fly
Hutchmed reports FY24 EPS 22c vs. 59c last year
2M ago
HUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
Premium
Company Announcements
HUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
2M ago
HUTCHMED Announces EGM for Strategic Disposal Approval
PremiumCompany AnnouncementsHUTCHMED Announces EGM for Strategic Disposal Approval
2M ago
Hutchmed completes enrollment of fanregratinib trial
Premium
The Fly
Hutchmed completes enrollment of fanregratinib trial
2M ago
HUTCHMED Appoints Alvin Wong as Independent Non-executive Director
Premium
Company Announcements
HUTCHMED Appoints Alvin Wong as Independent Non-executive Director
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100